Sunday, February 19, 2006

Reckitt - Boots as a starter. Now Pfizer as the main course?

Fresh from gobbling up a £1.9bn purchase of Boots' over-the-counter medicines business, Reckitt Benckiser may now be eying an even bigger dish; the $14bn (£8bn) consumer healthcare business of Pfizer.

Pfizer announced earlier this month that it would explore "strategic alternatives", including a sale or spin-off of the business, which is home to a host of household names such as Rogaine, Listerine and Sudafed.

It has hired Lazard to run the auction.

Source: The Independent

No comments: